Damage to small blood vessels of the eye appears to be a significant marker for an increased risk of stroke in patients with diabetes, suggesting that the microvascular pathology inherent to diabetic retinopathy may have greater cardiovascular implications, according to a study presented at the American Stroke Association’s (ASA) International Stroke Conference (ISC) 2020 in Los Angeles, US.
The lutein and zeaxanthin status in pregnant women may play a significant role in the visual developmental trajectory of their offspring, such that higher concentrations of these two carotenoids protect against the risk of poor visual acuity (VA) in children, as reported in a study from Singapore.
Unusual involvement of the eyes with atypical presentations may occur in patients with inflammatory bowel diseases (IBD) on antitumour necrosis factor (anti-TNF) therapy, according to a recent study presented at the 2019 Advances in Inflammatory Bowel Diseases Annual Meeting (AIBD 2019).
Short sleep duration appears to be linked to moderate diabetic retinopathy (DR), according to a new Singapore study. Parameters related to obstructive sleep apnoea, as well as high insomnia risk, are also additionally associated with vision-threatening (VT) DR and diabetic macular oedema (DME).
Asians who use angiotensin-converting enzyme inhibitors, fibrates, alpha-glucosidase inhibitors or insulin are likely to have cortical cataract, independent of the presence of hypertension, hyperlipidaemia or diabetes, according to data from the Singapore Epidemiology of Eye Diseases (SEED) study.
The fixed-dose combination of brinzolamide 1% and brimonidine 0.2% (BBFC) is superior to vehicle in lowering intraocular pressure (IOP) over a 24-hour period following 4 weeks of 3-times-daily treatment in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT), a study has shown.
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Percutaneous coronary intervention (PCI), compared with coronary artery bypass grafting (CABG), in the revascularization of left main coronary artery (LMCA) disease may lead to death, myocardial infarction (MI), or stroke in patients with moderate or severe left ventricular (LV) dysfunction, reveals a study.